A Prospective, Single-arm, Multi-centre, Blinded, Observational, Diagnostic Accuracy Study With a Diagnostic Medical Product
Launched by ISAR-M GMBH · Apr 13, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving the detection of serious bleeding after thyroid surgery. Normally, some patients may experience bleeding that can be dangerous, especially within the first two days after the operation. The trial is looking at a new method that continuously measures pressure in the neck area after surgery. By doing this, doctors hope to catch any increase in pressure early, which could signal bleeding before patients notice any symptoms. This early detection could help doctors take action more quickly, potentially reducing the risk of serious complications, such as brain damage or even death.
To participate in the trial, individuals must be at least 18 years old and scheduled to undergo thyroid surgery, like a total or partial removal of the thyroid gland. Participants will need to provide consent and cannot be using drains as part of their treatment. Those who join the study can expect to have their neck pressure monitored continuously after surgery, which will help researchers understand how effective this new method is at preventing serious complications from bleeding.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥18 years.
- • Indication for thyroid surgery (e.g. total thyroidectomy, subtotal resection, partial resection or lobectomy) in routine clinical care according to applicable medical guidelines using all adequate surgical approaches.
- • Signed informed consent
- Exclusion Criteria:
- • - Intended use of drains
About Isar M Gmbh
isar-m GmbH is a clinical trial sponsor specializing in the development and management of innovative therapies across various therapeutic areas. With a commitment to advancing medical research, isar-m GmbH collaborates with healthcare professionals and research institutions to conduct high-quality clinical trials that prioritize patient safety and efficacy. The company leverages its expertise in regulatory affairs, trial design, and data management to facilitate the successful execution of clinical studies, ultimately contributing to the advancement of healthcare solutions and improved patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hausham, , Germany
Patients applied
Trial Officials
Markus MA Albertsmeier, Dr.
Study Chair
Clinic for General, Visceral, Vascular and Transplant Surgery - Großhadern Campus,
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials